Benefits of FDA Orphan Drug Designation: What You Need to Know

By AGT | Apr 6, 2020

by Irene Tennant VP of Clinical Product Development and Regulatory Affairs Developing treatments for rare diseases has many challenges. These challenges are different and, in many ways, more complex than what is experienced during development of a drug intended for a larger patient population. The complexities can range from scientific, ethical and operational to financial. Due to these hurdles, the… [Read More]

Subscribe to Our Newsletter

Subscribe to our newsletter to keep up to date with all the latest news about AGT!

Mailchimp sidebar

Follow AGT on Social Media

Send this to a friend